Domain Partners VIII L.P. 13D/13G Filings for Milestone Pharmaceuticals Inc. (MIST)

Domain Partners VIII L.P. 13D and 13G filings for Milestone Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-01-20
6:33 pm
Sale
2020-12-3113GMilestone Pharmaceuticals Inc.
MIST
Domain Partners VIII L.P.860,724
2.900%
-1,012,381decrease
(-54.05%)
Filing